Comparing the Immunogenicity of AS03-Adjuvanted 2009 Pandemic H1N1 Vaccine with Clinical Protection in Priority Risk Groups in England

In England, during pandemic 2009 H1N1, vaccine efficacy and immunogenicity population studies in priority groups were rolled out in parallel to evaluate the pandemic vaccination programme. This provided a unique opportunity to compare immunogenicity and clinical protection in the same population and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yung, Chee-Fu, Andrews, Nick, Hoschler, Katja, Miller, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579930/
https://www.ncbi.nlm.nih.gov/pubmed/23451097
http://dx.doi.org/10.1371/journal.pone.0056844

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579930/
https://www.ncbi.nlm.nih.gov/pubmed/23451097
http://dx.doi.org/10.1371/journal.pone.0056844

Ejemplares similares